Data / Drug companies / Amway Corp
Amway Corp: 40 products in the FDA NDC directory, labeler code 50390
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Amway Corp (labeler code 50390) lists 40 products in the FDA National Drug Code Directory, covering 4 finished drugs by generic name. By type: 40 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on September 23, 2017.
The request: Watch Amway Corp (FDA labeler code 50390): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 50390
- Products in commercial distribution
- 40
- Packages
- 40
- Finished drugs by generic name
- 4
- Prescription products
- 0
- Over the counter products
- 40
- Flagged as original packager
- 40 of 40 products that carry the flag
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- May 6, 2013
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 40 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 40 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Titanium dioxide | 17 | 51 |
| Octinoxate, oxybenzone | 17 | 7 |
| Octinoxate, octisalate, zinc oxide, titanium dioxide | 1 | 1 |
| Ensulizole, octinoxate, zinc oxide | 1 | 1 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Cream | 40 | 100% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Copper Absorption Inhibitor | 5 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Artistry Ideal Radiance Illuminating CC SPF 50 Broad Spectrum Med/Deep | 50390-011 | Cream | Over the counter monograph drugs | September 23, 2017 |
| Artistry Ideal Radiance Illuminating CC SPF 50 Broad Spectrum Sunscreen Deep | 50390-010 | Cream | Over the counter monograph drugs | September 23, 2017 |
| Artistry Beauty Balm Perfecting Primer SPF 35 Broad Spectrum Sunscreen | 50390-004 | Cream | Over the counter monograph drugs | May 5, 2015 |
| Artistry Exact Fit Longwearing Foundation Shade Sand L2W1 | 50390-215 | Cream | Over the counter monograph drugs | May 1, 2015 |
| Artistry Exact Fit Longwearing Foundation Shade Plush L3C1 | 50390-214 | Cream | Over the counter monograph drugs | May 1, 2015 |
| Artistry Exact Fit Longwearing Foundation Shade Natural L2N2 | 50390-213 | Cream | Over the counter monograph drugs | May 1, 2015 |
| Artistry Exact Fit Longwearing Foundation Shade Caramel L5N1 | 50390-212 | Cream | Over the counter monograph drugs | May 1, 2015 |
| Artistry Exact Fit Longwearing Foundation Shade Cappuccino L5W1 | 50390-211 | Cream | Over the counter monograph drugs | May 1, 2015 |
| Artistry Exact Fit Longwearing Foundation Shade Walnut L6N1 | 50390-210 | Cream | Over the counter monograph drugs | May 1, 2015 |
| Artistry Exact Fit Longwearing Foundation Shade Tawny L3N1 | 50390-209 | Cream | Over the counter monograph drugs | May 1, 2015 |
| Artistry Exact Fit Longwearing Foundation Shade Soleil L3W1 | 50390-208 | Cream | Over the counter monograph drugs | May 1, 2015 |
| Artistry Exact Fit Longwearing Foundation Shade Ochre L2N1 | 50390-207 | Cream | Over the counter monograph drugs | May 1, 2015 |
| Artistry Exact Fit Longwearing Foundation Shade Mink L6W1 | 50390-206 | Cream | Over the counter monograph drugs | May 1, 2015 |
| Artistry Exact Fit Longwearing Foundation Shade Golden L4N1 | 50390-205 | Cream | Over the counter monograph drugs | May 1, 2015 |
| Artistry Exact Fit Longwearing Foundation Shade Cream L1W2 | 50390-204 | Cream | Over the counter monograph drugs | May 1, 2015 |
| Artistry Exact Fit Longwearing Foundation Shade Chiffon L2C1 | 50390-203 | Cream | Over the counter monograph drugs | May 1, 2015 |
| Artistry Exact Fit Longwearing Foundation Shade Chablis L1C1 | 50390-202 | Cream | Over the counter monograph drugs | May 1, 2015 |
| Artistry Exact Fit Longwearing Foundation Shade Buff L1W1 | 50390-201 | Cream | Over the counter monograph drugs | May 1, 2015 |
| Artistry Exact Fit Longwearing Foundation Shade Brule L4W1 | 50390-200 | Cream | Over the counter monograph drugs | May 1, 2015 |
| Artistry Exact Fit Longwearing Foundation SPF 15 Broad Spectrum Sunscreen | 50390-003 | Cream | Over the counter monograph drugs | May 1, 2015 |
| Artistry Ideal Radiance Illuminating CC SPF 50 Broad Spectrum Sunscreen Medium | 50390-002 | Cream | Over the counter monograph drugs | May 1, 2015 |
| Artistry Ideal Radiance Illuminating CC SPF 50 Broad Spectrum Sunscreen Light/Medium | 50390-001 | Cream | Over the counter monograph drugs | May 1, 2015 |
| ARTISTRY IDEAL RADIANCE UV Protect SPF 50 PLUS Broad Spectrum Sunscreen | 50390-108 | Cream | Over the counter monograph drugs | September 11, 2013 |
| Artistry Youth Xtend Lifting Smoothing Foundation Shade Plush L3C1 | 50390-242 | Cream | Over the counter monograph drugs | May 6, 2013 |
| Artistry Youth Xtend Lifting Smoothing Foundation Shade Natural L2N2 | 50390-241 | Cream | Over the counter monograph drugs | May 6, 2013 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.